Lonza Gent (Algonomics) (Public Company; LONN; Pharmaceuticals industry): Researcher, (March 2010-Present) Algonomics provides immunogenicity screening services for the biopharma industry, both in silico and in vitro. I'm involved in the crucial lab work: isolating PBMC from who...
Linkedin